Bausch Health Q2 2020 Earnings Report
Key Takeaways
Bausch Health reported revenues of $1.664 billion for Q2 2020, a decrease of 23% compared to Q2 2019, primarily due to the impact of the COVID-19 pandemic. The company had a GAAP net loss of $326 million and an adjusted EBITDA of $622 million. They also narrowed their 2020 full-year revenue and adjusted EBITDA guidance ranges.
Revenues of $1.664 Billion; Meaningfully Impacted by the COVID-19 Pandemic
GAAP Net Loss of $326 Million
Adjusted EBITDA (non-GAAP) of $622 Million
GAAP Cash Generated from Operations of $200 Million
Bausch Health
Bausch Health
Bausch Health Revenue by Segment
Forward Guidance
Bausch Health tightened its revenue and Adjusted EBITDA (non-GAAP) guidance ranges for the full year of 2020, primarily due to the actual and anticipated impacts of the COVID-19 pandemic.
Revenue & Expenses
Visualization of income flow from segment revenue to net income